Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03684187 · ClinicalTrials.gov registry record · NA
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03684187: Clinical Trial NA study, sponsored by Yale University.
NCT03684187 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03684187, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To assess the efficacy of mindfulness-based intervention (MBI) intervention in the treatment of moderate or severe fatigue in patients with primary biliary cholangitis (PBC).
Primary Outcome
Change in fatigue severity, assessed by the fatigue domain of the Primary Biliary Cholangitis-40 (PBC-40) questionnaire, of greater than 5 units at 16 weeks (end of MBI program) compared to baseline
Interventions
- BEHAVIORAL Mindfulness Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2023-04-17 |
| Phase | NA |
Why NCT03684187 stopped before completion
NCT03684187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Intervention is the first listed.
NCT03684187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03684187 about?
NCT03684187 is a clinical study titled "Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis". To assess the efficacy of mindfulness-based intervention (MBI) intervention in the treatment of moderate or severe fatigue in patients with primary biliary cholangitis (PBC).
What is the current status of trial NCT03684187?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-11-19. Estimated completion is 2023-04-17.
What interventions are being tested in trial NCT03684187?
The interventions under investigation include: Mindfulness Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03684187?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03684187's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI